Expression profiles of early esophageal squamous cell carcinoma by cDNA microarray

Cancer Genetics and Cytogenetics

Volumn 194, Issue 1, 2009, Pages 23-29

  Zhang, Xu ^a   Lin, Peng ^a   Zhu, Zhi Hua ^a   Long, Hao ^a   Wen, Jing ^a   Yang, Hong ^a   Zhang, Xing ^a   Wang, Dao Feng ^a   Fu, Jian Hua ^a   Fang, Yan ^a   Rong, Tie Hua ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; GUANINE NUCLEOTIDE BINDING PROTEIN; MOLECULAR MARKER; RNA; TRANSFORMING GROWTH FACTOR BETA;

ADULT; APOPTOSIS; ARTICLE; CANCER TISSUE; CARCINOGENESIS; CASE REPORT; CELL CYCLE; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; DNA MICROARRAY; EARLY DIAGNOSIS; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS MUCOSA; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE MAPPING; GENETIC SCREENING; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; MALE; METABOLISM; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RNA EXTRACTION; SIGNAL TRANSDUCTION;

CARCINOMA, SQUAMOUS CELL; CLUSTER ANALYSIS; EARLY DIAGNOSIS; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 69549089870     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2009.04.027     Document Type: Article

References (26)

1. Tang Y.Z. Esophageal carcinoma [In Chinese]. Modern oncology [In Chinese]. 2nd ed (2000), Fudan Publishing Company, Shanghai, China 658-694
2. Hu N., Huang J., Emmert-Buck M.R., Tang Z.Z., Roth M.J., Wang C., Dawsey S.M., Li G., Li W.J., Wang Q.H., Han X.Y., Ding T., Giffen C., Goldstein A.M., and Taylor P.R. Frequent inactivation of the TP53 gene in esophageal squamous cell carcinoma from a high-risk population in China. Clin Cancer Res 7 (2001) 883-1
3. Güner D., Sturm I., Hemmati P., Hermann S., Hauptmann S., Wurm R., Budach V., Dörken B., Lorenz M., and Daniel P.T. Multigene analysis of Rb pathway and apoptosis control in esophageal squamous cell carcinoma identifies patients with good prognosis. Int J Cancer 103 (2003) 445-454
4. ARF) and p53 genes are major targets for inactivation. Carcinogenesis 23 (2002) 645-655
5. Kuroki T., Trapasso F., Yendamuri S., Matsuyama A., Alder H., Mori M., and Croce C.M. Allele loss and promoter hypermethylation of VHL, RAR-β, RASSF1A, and FHIT tumor suppressor genes on chromosome 3p in esophageal squamous cell carcinoma. Cancer Res 63 (2003) 3724-3728
6. Tamoto E., Tada M., Murakawa K., Takada M., Shindo G., Teramoto K., Matsunaga A., Komuro K., Kanai M., Kawakami A., Fujiwara Y., Kobayashi N., Shirata K., Nishimura N., Okushiba S., Kondo S., Hamada J., Yoshiki T., Moriuchi T., and Katoh H. Gene-expression profile changes correlated with tumor progression and lymph node metastasis in esophageal cancer. Clin Cancer Res 10 (2004) 3629-3638
7. 2+-relevant and differentiation-associated genes downregulated in esophageal squamous cell carcinoma using cDNA microarray. Oncogene 23 (2004) 1291-1299
8. Kihara C., Tsunoda T., Tanaka T., Yamana H., Furukawa Y., Ono K., Kitahara O., Zembutsu H., Yanagawa R., Hirata K., Takagi T., and Nakamura Y. Prediction of sensitivity of esophageal tumors to adjuvant chemotherapy by cDNA microarray analysis of gene-expression profiles. Cancer Res 61 (2001) 6474-6479
9. Yamabuki T., Daigo Y., Kato T., Hayama S., Tsunoda T., Miyamoto M., Ito T., Fujita M., Hosokawa M., Kondo S., and Nakamura Y. Genome-wide gene expression profile analysis of esophageal squamous cell carcinomas. Int J Oncol 6 (2006) 1375-1384
10. Sato T., Iizuka N., Hamamoto Y., Yoshino S., Abe T., Takeda S., Uchimura S., Miyamoto T., Sei F., Hamada K., Yamada-Okabe H., and Oka M. Esophageal squamous cell carcinomas with distinct invasive depth show different gene expression profiles associated with lymph node metastasis. Int J Oncol 5 (2006) 1043-1055
11. Dar A.A., Zaika A., Piazuelo M.B., Correa P., Koyama T., Belkhiri A., Washington K., Castells A., Pera M., and El-Rifai W. Frequent overexpression of aurora kinase A in upper gastrointestinal adenocarcinomas correlates with potent antiapoptotic functions. Cancer 112 (2008) 1688-1698
12. Reiter R., Gais P., Jütting U., Steuer-Vogt M.K., Pickhard A., Bink K., Rauser S., Lassmann S., Höfler H., Werner M., and Walch A. Aurora kinase A messenger RNA overexpression is correlated with tumor progression and shortened survival in head and neck squamous cell carcinoma. Clin Cancer Res 12 (2006) 5136-5141
13. Jeng Y.M., Peng S.Y., Lin C.Y., and Hsu H.C. Overexpression and amplification of Aurora-A in hepatocellular carcinoma. Clin Cancer Res 10 (2004) 2065-2071
14. Lassmann S., Shen Y., Jütting U., Wiehle P., Walch A., Gitsch G., Hasenburg A., and Werner M. Predictive value of Aurora-A/STK15 expression for late stage epithelial ovarian cancer patients treated by adjuvant chemotherapy. Clin Cancer Res 13 (2007) 4083-4091
15. Kanehira M., Harada Y., Takata R., Shuin T., Miki T., Fujioka T., Nakamura Y., and Katagiri T. Involvement of upregulation of DEPDC1 (DEP domain containing 1) in bladder carcinogenesis. Oncogene 26 (2007) 6448-6455
16. Takakura S., Kohno T., Manda R., Okamoto A., Tanaka T., and Yokota J. Genetic alterations and expression of the protein phosphatase 1 genes in human cancers. Int J Oncol 18 (2001) 817-824
17. Lei Q., Jiao J., Xin L., Chang C.J., Wang S., Gao J., Gleave M.E., Witte O.N., Liu X., and Wu H. NKX3.1 stabilizes p53, inhibits AKT activation, and blocks prostate cancer initiation caused by PTEN loss. Cancer Cell 9 (2006) 367-378
18. Asatiani E., Huang W.X., Wang A., Rodriguez Ortner E., Cavalli L.R., Haddad B.R., and Gelmann E.P. Deletion, methylation, and expression of the NKX3.1 suppressor gene in primary human prostate cancer. Cancer Res 65 (2005) 1164-1173
19. Grabowski P., Kühnel T., Mühr-Wilkenshoff F., Heine B., Stein H., Höpfner M., Germer C.T., and Scherübl H. Prognostic value of nuclear survivin expression in oesophageal squamous cell carcinoma. Br J Cancer 88 (2003) 115-119
20. Rosato A., Pivetta M., Parenti A., Iaderosa G.A., Zoso A., Milan G., Mandruzzato S., Del Bianco P., Ruol A., Zaninotto G., and Zanovello P. Survivin in esophageal cancer: an accurate prognostic marker for squamous cell carcinoma but not adenocarcinoma. Int J Cancer 119 (2006) 1717-1722
21. Kondo K., Yamasaki S., Inoue N., Sugie T., Teratani N., Kan T., and Shimada Y. Prospective antitumor effects of the combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and cisplatin against esophageal squamous cell carcinoma. Surg Today 36 (2006) 966-974
22. Lung H.L., Bangarusamy D.K., Xie D., Cheung A.K., Cheng Y., Kumaran M.K., Miller L., Liu E.T., Guan X.Y., Sham J.S., Fang Y., Li L., Wang N., Protopopov A.I., Zabarovsky E.R., Tsao S.W., Stanbridge E.J., and Lung M.L. THY1 is a candidate tumour suppressor gene with decreased expression in metastatic nasopharyngeal carcinoma. Oncogene 24 (2005) 6525-6532
23. Abeysinghe H.R., Pollock S.J., Guckert N.L., Veyberman Y., Keng P., Halterman M., Federoff H.J., Rosenblatt J.P., and Wang N. The role of the THY1 gene in human ovarian cancer suppression based on transfection studies. Cancer Genet Cytogenet 149 (2004) 1-10
24. Fritzsche S., Kenzelmann M., Hoffmann M.J., Müller M., Engers R., Gröne H.J., and Schulz W.A. Concomitant down-regulation of SPRY1 and SPRY2 in prostate carcinoma. Endocr Relat Cancer 13 (2006) 839-9
25. Garraway L.A., Widlund H.R., Rubin M.A., Getz G., Berger A.J., Ramaswamy S., Beroukhim R., Milner D.A., Granter S.R., Du J., Lee C., Wagner S.N., Li C., Golub T.R., Rimm D.L., Meyerson M.L., Fisher D.E., and Sellers W.R. Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature 436 (2005) 117-122
26. Arai H., Ueno T., Tangoku A., Yoshino S., Abe T., Kawauchi S., Oga A., Furuya T., Oka M., and Sasaki K. Detection of amplified oncogenes by genome DNA microarrays in human primary esophageal squamous cell carcinoma: comparison with conventional comparative genomic hybridization analysis. Cancer Genet Cytogenet 1 (2003) 16-21